Abstract
It is well established in the scientific literature that only a small fraction of microorganisms can be cultured by conventional microbiology methods. The ever cheaper and faster DNA sequencing methods, together with advances in bioinformatics, have improved our understanding of the structure and functional behavior of microbial communities in many complex environments. However, the metagenomics approach alone cannot elucidate the functionality of all microorganisms, because a vast number of potentially new genes have no homologs in public databases. Metatranscriptomics and metaproteomics are approaches based on different techniques and have recently emerged as promising techniques to describe microbial activities within a given environment at the molecular level. In this review, we will discuss current developments and applications of metagenomics, metatranscriptomics and metaproteomics, and their limitations in the study of microbial communities. The combined analysis of genes, mRNA and protein in complex microbial environments will be key to identify novel biological molecules for biotechnological purposes.
Keywords: Metagenome, metaproteome, metatranscriptome and microbial diversity.
Current Protein & Peptide Science
Title:Combining “Omics” Strategies to Analyze the Biotechnological Potential of Complex Microbial Environments
Volume: 14 Issue: 6
Author(s): Alinne Pereira de Castro, Maria Regina Silveira Sartori da Silva, Betania Ferraz Quirino and Ricardo Henrique Kruger
Affiliation:
Keywords: Metagenome, metaproteome, metatranscriptome and microbial diversity.
Abstract: It is well established in the scientific literature that only a small fraction of microorganisms can be cultured by conventional microbiology methods. The ever cheaper and faster DNA sequencing methods, together with advances in bioinformatics, have improved our understanding of the structure and functional behavior of microbial communities in many complex environments. However, the metagenomics approach alone cannot elucidate the functionality of all microorganisms, because a vast number of potentially new genes have no homologs in public databases. Metatranscriptomics and metaproteomics are approaches based on different techniques and have recently emerged as promising techniques to describe microbial activities within a given environment at the molecular level. In this review, we will discuss current developments and applications of metagenomics, metatranscriptomics and metaproteomics, and their limitations in the study of microbial communities. The combined analysis of genes, mRNA and protein in complex microbial environments will be key to identify novel biological molecules for biotechnological purposes.
Export Options
About this article
Cite this article as:
Castro Pereira de Alinne, Silva Regina Silveira Sartori da Maria, Quirino Ferraz Betania and Kruger Henrique Ricardo, Combining “Omics” Strategies to Analyze the Biotechnological Potential of Complex Microbial Environments, Current Protein & Peptide Science 2013; 14 (6) . https://dx.doi.org/10.2174/13892037113149990062
DOI https://dx.doi.org/10.2174/13892037113149990062 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Comparison Between the Effects of Bupivacaine and Levobupivacaine for Spinal Anesthesia on QT Dispersion
Cardiovascular & Hematological Disorders-Drug Targets Exploring QSAR of Flavonoids as Scavengers of Peroxynitrite Using Electrotopological State (E-State) Atom Parameter
Letters in Drug Design & Discovery Hyaluronidase Inhibitors: A Biological and Therapeutic Perspective
Current Medicinal Chemistry Cardiomyocyte-Specific TβR2 Knockout Mice are More Susceptible to Cardiac Hypertrophy Induced by Adrenergic Agonist Stimulation
Current Molecular Medicine Getting Patients to Target- Implementing the Guidelines
Current Vascular Pharmacology Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical Agents and Current Vaccines Against COVID-19
Current Stem Cell Research & Therapy Effect of Aging On Angiogenesis and Arteriogenesis
Current Cardiology Reviews Current Research Issues in the Pharmacokinetics of Antiretroviral Drugs in Children
Current Pediatric Reviews Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Pharmacological Treatments for Obesity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Pulmonary Valve Endocarditis: A Case Report
Infectious Disorders - Drug Targets Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Cystathionine Beta Synthase as a Risk Factor for Alzheimer Disease
Current Alzheimer Research Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
Current Pharmaceutical Design Stem Cell Therapies for the Lysosomal Storage Diseases – the Quintessential Neurodegenerative Diseases
Current Stem Cell Research & Therapy